Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Takeda Pharmaceutical Company Limited company logo
Takeda Pharmaceutical Company Limited logo

Takeda Pharmaceutical Company Limited (TAK)

Summary

As of today, TAK price is $17.76, down -2.52% on
TAK price is currently -43.24% below its historical high of $31.29 set on
TAK current market cap is $56B, up +18.38% over the past 365 days
TAK current PE ratio is 73.75
TAK current annual revenue is $30.05B, up +1.92% year-over-year
The next earnings release for TAK is on

Profile

Company profile for Takeda Pharmaceutical Company Limited (TAK)
MetricValue
Full NameTakeda Pharmaceutical Company Limited
TickerNYSE: TAK
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryJapan
IPO
IndexesNot included
Websitetakeda.com
Employees47,455

Key Metrics

Takeda Pharmaceutical Company Limited Key Details
MetricDateValue
Price$17.76
Price, 1D Change-2.52%
Market Cap$56B
TTM Dividend Yield3.72%
PE Ratio73.75
Beta0.23
Revenue$30B
Revenue, 1Y Change+1.92%
EPS$0.22
EPS, 1Y Change-30.04%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Takeda Pharmaceutical Company Limited chart

Events

Takeda Pharmaceutical Company Limited Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.32
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeTKPYY
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TAK Estimates
MetricDateValue
EPS$0.22
EPS Estimate$49.21
EPS Est. Change+22,215.65%
Revenue$30.05B
Revenue Estimate$4,528.86B
Revenue Est. Change+14,969.71%
Current Price$17.76
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

TAK EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$0.34$0.32-7.29%
-$0.22-
$49.21N/A+22,215.65%
$94.98N/A+42,975.74%
TAK EPS reported versus estimate values chart

Revenue

TAK revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$26.65M$29.49B+110,542.13%
$4,611.64B$30.05B-99.35%
$4,528.86BN/A+14,969.71%
$4,571.79BN/A+15,112.55%
TAK revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TAK Performance
MetricDateValue
Price, 1Y+18.40%
Price, 3Y+13.55%
Market Cap, 1Y+18.38%
Market Cap, 3Y+14.94%
Revenue, 1Y+1.92%
Revenue, 3Y-5.38%
EPS, 1Y-30.04%
EPS, 3Y-66.02%

🔒 Log In To Unlock Full Data

Technical Indicators

TAK Technical Indicators
MetricDateValue
Current Price$17.76
SMA 200$15.21
SMA 200 vs Price-14.34%
SMA 50$17.08
SMA 50 vs Price-3.83%
Beta0.23
ATR$0.33
14-Day RSI47.14
10-Day Volatility19.77%
1-Year Volatility20.59%

Dividends

TAK Dividends
MetricDateValue
Last Paid$0.32
UpcomingN/AN/A
Dividend Yield3.74%
Total Dividend$0.67
$1.98B
279.72%

🔒 Log In To Unlock Full Data

Income & Profitability

TAK Income & Profitability
MetricDateValue
Revenue$30.05B
EPS$0.22
Gross Profit$16.10B
Gross Margin53.59%
Operating Profit$4.12B
Operating Margin-32.71%
Net Income$709.37M
Net Margin2.36%
EBITDA$9.11B

🔒 Log In To Unlock Full Data

Financial Health

TAK Financial Health
MetricDateValue
Debt To Equity0.73
1.01
0.52
-
8
1.26

Valuations

TAK Valuations
MetricDateValue
PE Ratio73.75
1.88
1.15
9.58
N/A-

Balance Sheet

TAK Balance Sheet
MetricDateValue
Book Value$46.38B
$2.58B
$95.28B
$16.86B
$48.90B
$16.76B
Total Debt$34.03B
$4.10B
$2.06B

Expenses

TAK Expenses
MetricDateValue
$29.34B
$11.99B
$13.95B
$7.25B
$4.99B
$0.00
$439.10M

Cash Flow

TAK Cash Flow
MetricDateValue
$6.31B
-$2.53B
-$4.19B
Capex$2.28B
$4.03B

Recent analyst updates

TAK Recent analyst updates
MetricDateValue
TD Cowen→
TD Cowen
B of A Securities→
Cowen & Co.→
Morgan Stanley→
JP Morgan
Cowen & Co.
Jefferies

Analyst sentiment

Sentiment over the past month
TAK analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TAK institutional ownership distribution chart

Screeners with TAK

FAQ

  • What is the ticker symbol for Takeda Pharmaceutical Company Limited?

    The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK

  • Does Takeda Pharmaceutical Company Limited pay dividends?

    Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.32, with an ex-dividend date on September 29, 2025

  • What sector is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Healthcare sector

  • What industry is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Specialty & Generic Drug Manufacturers industry

  • What country is Takeda Pharmaceutical Company Limited based in?

    Takeda Pharmaceutical Company Limited is headquartered in Japan

  • When did Takeda Pharmaceutical Company Limited go public?

    Takeda Pharmaceutical Company Limited initial public offering (IPO) was on January 5, 2010

  • Is Takeda Pharmaceutical Company Limited in the S&P 500?

    No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index

  • Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?

    No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index

  • Is Takeda Pharmaceutical Company Limited in the Dow Jones?

    No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index

  • When was Takeda Pharmaceutical Company Limited last earnings report?

    Takeda Pharmaceutical Company Limited's most recent earnings report was on January 29, 2026

  • When does Takeda Pharmaceutical Company Limited report earnings?

    The next expected earnings date for Takeda Pharmaceutical Company Limited is May 13, 2026

Data Sources & References

  1. TAK Official Website www.takeda.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1395064/000139506426000002/0001395064-26-000002-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
  4. TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
  5. TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak